No, cortisol testing is NOT required before initiating glucocorticoid therapy
Cortisol levels should NOT be routinely measured before starting glucocorticoid treatment. The question of cortisol testing relates to discontinuing or tapering glucocorticoids, not initiating them. 1
When Cortisol Testing IS Relevant (During Glucocorticoid Discontinuation)
The 2024 European Society of Endocrinology/Endocrine Society joint guidelines provide clear direction on when cortisol testing becomes important:
Do NOT test cortisol in these situations:
- Short-term therapy (<3-4 weeks): Glucocorticoids can be stopped abruptly without testing, regardless of dose, due to low concern for HPA axis suppression 1
- Patients still on supraphysiologic doses: Testing is not recommended while patients remain on doses above physiologic replacement (e.g., >4-6 mg prednisone daily) 1
- Active disease requiring continued treatment: Testing should only occur when the underlying condition is controlled and glucocorticoids are no longer needed 1
Consider cortisol testing only when:
The patient has reached physiologic dose equivalents (4-6 mg prednisone or 15-25 mg hydrocortisone daily) AND is attempting to discontinue therapy 1
At this point, you have two acceptable approaches 1:
- Continue gradual taper with clinical monitoring for adrenal insufficiency symptoms
- Measure morning serum cortisol to guide discontinuation
How to Perform Cortisol Testing (If Chosen)
Morning serum cortisol is the recommended first test 1:
- Draw between 8:00-9:00 AM
- Hold glucocorticoid dose for at least 24 hours before testing (except dexamethasone, which requires longer)
- Interpret as a continuum, not absolute cutoffs 1
Interpretation thresholds 1:
- >300 nmol/L (10 μg/dL): HPA axis recovered, safe to stop glucocorticoids
- 150-300 nmol/L (5-10 μg/dL): Continue physiologic dose, recheck in weeks to months
- <150 nmol/L (5 μg/dL): Continue physiologic dose, recheck in several months
Critical Pitfalls to Avoid
Do not over-interpret low cortisol values during tapering. Recent evidence shows that 42% of patients who successfully discontinued glucocorticoids had nadir morning cortisol <150 nmol/L, including some with values <28 nmol/L, without experiencing adrenal crises 2. The HPA axis recovers during physiological dose tapering, not before it.
Factors that falsely alter cortisol measurements 1:
- Elevated in: pregnancy, oral estrogen use (increased cortisol-binding globulin)
- Decreased in: hypoalbuminemia (cirrhosis, nephrotic syndrome, malnutrition), critical illness
- Disrupted circadian rhythm (night shift workers, jet lag, severe insomnia) can falsely lower morning values
Dynamic testing (ACTH stimulation) is NOT routinely recommended during glucocorticoid taper 1. The guidelines explicitly suggest against routine dynamic testing, as biochemical adrenal insufficiency is common but clinically significant adrenal crisis remains very rare 1.
Special Populations Requiring Awareness
Be alert for glucocorticoid-induced adrenal insufficiency in patients with 1:
- Non-oral formulations (inhaled, topical, intra-articular injections within 2 months)
- Multiple simultaneous glucocorticoid formulations
- High-dose inhaled/topical glucocorticoids or use >1 year
- Concomitant strong CYP3A4 inhibitors
- Signs of exogenous Cushing syndrome (assume adrenal insufficiency) 1
Patients without biochemical testing who face physiologic stress should receive stress-dose glucocorticoid coverage 1. This is a safety measure when adrenal function status is unknown.